It will complement GenCure's other biomanufacturing operations at BioBridge Global's headquarters in Northwest San Antonio. “We are developing a ...
News
- BioBridge Global restructuring to boost GenCure business
- Neurocrine Biosciences, Inc. (NBIX) Reaches $91.19 After 7.00% Up Move; Hff Class A (HF) Shorts ...
The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is a huge mover today! ... which released: “Chicago company acquires Children’s Hospital of San Antonio Pavilion – San Antonio Business Journal” on April 04, 2019, ...
- UTSA welcomes gene therapy pioneer Brian Kaspar for April 10 Distinguished Lecture
AveXis, Inc., a Novartis Company, is a clinical-stage gene therapy biotechnology company, focused on the treatment of neurological diseases.
- Waterfront Capital Partners Has Boosted By $5.40 Million Its Retail Pptys Amer (RPAI) Position ...
CURATIVE BIOSCIENCES INC (OTCMKTS:CBDX) had an increase of ... Oaks In The San Antonio MSA; 14/05/2018 – Resolution Capital Buys New ...
- UT Health San Antonio launching new technology accelerator
TechNovum will get support from the San Antonio Life Sciences Institute, a joint program of UT Health San Antonio and the University of Texas at San ...